Journal of Gastric Cancer

  • 제24권1호
  • /
  • Pages.89-98
  • /
  • 2024
  • /
  • 2093-582X(pISSN)
  • /
  • 2093-5641(eISSN)
대한위암학회 (The Korean Gastric Cancer Association)
권호 표지
DOI QR코드

DOI QR Code

Unveiling the Gastrointestinal Microbiome Symphony: Insights Into Post-Gastric Cancer Treatment Microbial Patterns and Potential Therapeutic Avenues

  • Chan Hyuk Park (Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine)
  • 투고 : 2023.11.12
  • 심사 : 2023.12.04
  • 발행 : 2024.01.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

This review delved into the intricate relationship between the gastrointestinal microbiome and gastric cancer, particularly focusing on post-treatment alterations, notably following gastrectomy, and the effects of anticancer therapies. Following gastrectomy, analysis of fecal samples revealed an increased presence of oral cavity aerotolerant and bile acid-transforming bacteria in the intestine. Similar changes were observed in the gastric microbiome, highlighting significant alterations in taxon abundance and emphasizing the reciprocal interaction between the oral and gastric microbiomes. In contrast, the impact of chemotherapy and immunotherapy on the gut microbiome was subtle, although discernible differences were noted between treatment responders and non-responders. Certain bacterial taxa showed promise as potential prognostic markers. Notably, probiotics emerged as a promising approach for postgastrectomy recovery, displaying the capacity to alleviate inflammation, bolster immune responses, and maintain a healthy gut microbiome. Several strains, including Bifidobacterium, Lactobacillus, and Clostridium butyricum, exhibited favorable outcomes in postoperative patients, suggesting their potential roles in comprehensive patient care. In conclusion, understanding the intricate interplay between the gastrointestinal microbiome and gastric cancer treatment offers prospects for predicting responses and enhancing postoperative recovery. Probiotics, with their positive impact on inflammation and immunity, have emerged as potential adjuncts in patient care. Continued research is imperative to fully harness the potential of microbiome-based interventions in the management of gastric cancer.

키워드

과제정보

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIT) (No. NRF-2021R1C1C1005728) (C.H.P.). Figs. 1 and 2 were created using Biorender.

참고문헌

  1. Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 1977;31:107-133. https://doi.org/10.1146/annurev.mi.31.100177.000543
  2. Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol 2016;14:e1002533.
  3. Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, et al. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci U S A 2006;103:732-737. https://doi.org/10.1073/pnas.0506655103
  4. Park CH, Seo SI, Kim JS, Kang SH, Kim BJ, Choi YJ, et al. Treatment of non-erosive reflux disease and dynamics of the esophageal microbiome: a prospective multicenter study. Sci Rep 2020;10:15154.
  5. Park CH, Lee SK. Exploring esophageal microbiomes in esophageal diseases: a systematic review. J Neurogastroenterol Motil 2020;26:171-179. https://doi.org/10.5056/jnm19240
  6. Park CH, Lee AR, Lee YR, Eun CS, Lee SK, Han DS. Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing. Helicobacter 2019;24:e12547.
  7. Park CH. Changes in gastric microbial composition before and after Helicobacter pylori eradication therapy. Korean J Helicobacter Up Gastrointest Res 2020;20:177-186. https://doi.org/10.7704/kjhugr.2020.0028
  8. Park CH, Hong C, Lee AR, Sung J, Hwang TH. Multi-omics reveals microbiome, host gene expression, and immune landscape in gastric carcinogenesis. iScience 2022;25:103956.
  9. Chen CC, Liou JM, Lee YC, Hong TC, El-Omar EM, Wu MS. The interplay between Helicobacter pylori and gastrointestinal microbiota. Gut Microbes 2021;13:1-22. https://doi.org/10.1080/19490976.2021.1909459
  10. Park CH, Han DS, Oh YH, Lee AR, Lee YR, Eun CS. Role of Fusobacteria in the serrated pathway of colorectal carcinogenesis. Sci Rep 2016;6:25271.
  11. Maksimaityte V, Bausys A, Kryzauskas M, Luksta M, Stundiene I, Bickaite K, et al. Gastrectomy impact on the gut microbiome in patients with gastric cancer: a comprehensive review. World J Gastrointest Surg 2021;13:678-688. https://doi.org/10.4240/wjgs.v13.i7.678
  12. Whittaker RH. Evolution and measurement of species diversity. Taxon 1972;21:213-251. https://doi.org/10.2307/1218190
  13. Chao A, Chiu CH, Jost L. Phylogenetic diversity measures and their decomposition: a framework based on hill numbers. In: Pellens R, Grandcolas P, eds. Biodiversity Conservation and Phylogenetic Systematics: Preserving Our Evolutionary Heritage in an Extinction Crisis. Cham: Springer International Publishing, 2016:141-172. 
  14. Spellerberg I, Fedor P. A tribute to Claude Shannon (1916-2001) and a plea for more rigorous use of species richness, species diversity and the 'Shannon-Wiener' Index. Glob Ecol Biogeogr 2003;12:177-179. https://doi.org/10.1046/j.1466-822X.2003.00015.x
  15. Tuomisto H. A diversity of beta diversities: straightening up a concept gone awry. Part 1. Defining beta diversity as a function of alpha and gamma diversity. Ecography 2010;33:2-22. https://doi.org/10.1111/j.1600-0587.2009.05880.x
  16. Bray JR, Curtis JT. An ordination of the upland forest communities of Southern Wisconsin. Ecol Monogr 1957;27:325-349. https://doi.org/10.2307/1942268
  17. Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 2005;71:8228-8235. https://doi.org/10.1128/AEM.71.12.8228-8235.2005
  18. Erawijantari PP, Mizutani S, Shiroma H, Shiba S, Nakajima T, Sakamoto T, et al. Influence of gastrectomy for gastric cancer treatment on faecal microbiome and metabolome profiles. Gut 2020;69:1404-1415. https://doi.org/10.1136/gutjnl-2019-319188
  19. Celiker H. A new proposed mechanism of action for gastric bypass surgery: air hypothesis. Med Hypotheses 2017;107:81-89. https://doi.org/10.1016/j.mehy.2017.08.012
  20. Chen T, Yu WH, Izard J, Baranova OV, Lakshmanan A, Dewhirst FE. The Human Oral Microbiome Database: a web accessible resource for investigating oral microbe taxonomic and genomic information. Database (Oxford) 2010;2010:baq013.
  21. Franzosa EA, McIver LJ, Rahnavard G, Thompson LR, Schirmer M, Weingart G, et al. Species-level functional profiling of metagenomes and metatranscriptomes. Nat Methods 2018;15:962-968. https://doi.org/10.1038/s41592-018-0176-y
  22. Ilhan ZE, DiBaise JK, Isern NG, Hoyt DW, Marcus AK, Kang DW, et al. Distinctive microbiomes and metabolites linked with weight loss after gastric bypass, but not gastric banding. ISME J 2017;11:2047-2058. https://doi.org/10.1038/ismej.2017.71
  23. Lin XH, Huang KH, Chuang WH, Luo JC, Lin CC, Ting PH, et al. The long term effect of metabolic profile and microbiota status in early gastric cancer patients after subtotal gastrectomy. PLoS One 2018;13:e0206930.
  24. Horvath A, Bausys A, Sabaliauskaite R, Stratilatovas E, Jarmalaite S, Schuetz B, et al. Distal gastrectomy with Billroth II reconstruction is associated with oralization of gut microbiome and intestinal inflammation: a proof-of-concept study. Ann Surg Oncol 2021;28:1198-1208. https://doi.org/10.1245/s10434-020-08678-1
  25. Liang W, Yang Y, Wang H, Wang H, Yu X, Lu Y, et al. Gut microbiota shifts in patients with gastric cancer in perioperative period. Medicine (Baltimore) 2019;98:e16626.
  26. Tseng CH, Lin JT, Ho HJ, Lai ZL, Wang CB, Tang SL, et al. Gastric microbiota and predicted gene functions are altered after subtotal gastrectomy in patients with gastric cancer. Sci Rep 2016;6:20701.
  27. Park S, Chun HJ. Helicobacter pylori infection following partial gastrectomy for gastric cancer. World J Gastroenterol 2014;20:2765-2770. https://doi.org/10.3748/wjg.v20.i11.2765
  28. Imai Y, Lee SW, Sakaguchi S, Kato-Kogoe N, Taniguchi K, Omori M, et al. Comparison of the gastric microbiome in Billroth I and Roux-en-Y reconstructions after distal gastrectomy. Sci Rep 2022;12:10594.
  29. Komori E, Kato-Kogoe N, Imai Y, Sakaguchi S, Taniguchi K, Omori M, et al. Changes in salivary microbiota due to gastric cancer resection and its relation to gastric fluid microbiota. Sci Rep 2023;13:15863.
  30. Peng X, Cheng L, You Y, Tang C, Ren B, Li Y, et al. Oral microbiota in human systematic diseases. Int J Oral Sci 2022;14:14.
  31. Wang B, Zhang Y, Zhao Q, Yan Y, Yang T, Xia Y, et al. Patients with reflux esophagitis possess a possible different oral microbiota compared with healthy controls. Front Pharmacol 2020;11:1000.
  32. Liang T, Liu F, Liu L, Zhang Z, Dong W, Bai S, et al. Effects of Helicobacter pylori infection on the oral microbiota of reflux esophagitis patients. Front Cell Infect Microbiol 2021;11:732613.
  33. Dzunkova M, Liptak R, Vlkova B, Gardlik R, Cierny M, Moya A, et al. Salivary microbiome composition changes after bariatric surgery. Sci Rep 2020;10:20086.
  34. Chen C, Shen J, Du Y, Shi X, Niu Y, Jin G, et al. Characteristics of gut microbiota in patients with gastric cancer by surgery, chemotherapy and lymph node metastasis. Clin Transl Oncol 2022;24:2181-2190. https://doi.org/10.1007/s12094-022-02875-y
  35. Han Z, Cheng S, Dai D, Kou Y, Zhang X, Li F, et al. The gut microbiome affects response of treatments in HER2-negative advanced gastric cancer. Clin Transl Med 2023;13:e1312.
  36. Zheng C, Chen T, Wang Y, Gao Y, Kong Y, Liu Z, et al. A randomised trial of probiotics to reduce severity of physiological and microbial disorders induced by partial gastrectomy for patients with gastric cancer. J Cancer 2019;10:568-576. https://doi.org/10.7150/jca.29072
  37. Cao W, Zheng C, Xu X, Jin R, Huang F, Shi M, et al. Clostridium butyricum potentially improves inflammation and immunity through alteration of the microbiota and metabolism of gastric cancer patients after gastrectomy. Front Immunol 2022;13:1076245.
  38. Pan LL, Niu W, Fang X, Liang W, Li H, Chen W, et al. Clostridium butyricum strains suppress experimental acute pancreatitis by maintaining intestinal homeostasis. Mol Nutr Food Res 2019;63:e1801419.
  39. Murayama T, Mita N, Tanaka M, Kitajo T, Asano T, Mizuochi K, et al. Effects of orally administered Clostridium butyricum MIYAIRI 588 on mucosal immunity in mice. Vet Immunol Immunopathol 1995;48:333-342. https://doi.org/10.1016/0165-2427(95)05437-B